Literature DB >> 11845847

Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years.

Ken Kodama1, Masahiko Higashiyama, Hideoki Yokouchi, Koji Takami, Keiko Kuriyama, Yoko Kusunoki, Tomio Nakayama, Fumio Imamura.   

Abstract

BACKGROUND: Pure ground-glass opacity (PGGO) is a new entity that has been clearly defined on high-resolution computed tomography (CT) during the last half decade. It is important to investigate the natural history of PGGO through long-term observation for the management of this new entity.
METHODS: We investigated 19 patients with PGGO(s) defined on high-resolution computed tomography and retained as PGGO for more than 2 years. The PGGOs of 11 patients were detected at annual mass screening by low-radiation-dose CT (low-dose CT), 7 at follow-up CT after cancer resection, and 1 incidentally on CT. After long-term observation, 10 of 19 patients underwent operation and 9 are currently being followed-up with CT. Their growth characteristics and histologic findings are reported.
RESULTS: The median follow-up period was 32 months, ranging from 24 to 124 months. The sizes of PGGOs at the time of discovery were 4 to 18 mm in largest diameter (average 8.6 mm). During follow-up, the size of PGGO showed no change in 8 patients, increased slightly (up to 5 mm) in 6 patients, and increased by more than 5 mm in 5 patients. Ten patients had limited resection (segmentectomy or wide wedge resection) with negative surgical margin by intraoperative lavage cytology of the resection margin of the lung. Of them, 5 patients had adenocarcinoma, 3 pulmonary lymphoproliferative disorder, and 1 each atypical adenomatous hyperplasia and focal fibrosis. There was no clear tendency between the degree of size change and histology. In all but 1 of 9 patients with follow-up only, the PGGOs showed either no change or only a slight increase within 5 mm in largest diameter.
CONCLUSIONS: These data suggest that some PGGOs will never progress to clinical disease and would be included in the category of overdiagnosis bias. However, a prior history of lung cancer should significantly raise the index of suspicion, as 4 of 5 proven cancer cases in this small series fell into that category. Because of the difficulties of preoperative and intraoperative histodiagnosis of PGGO, minimally invasive surgery may be appropriate from the viewpoints of both diagnosis and curability.

Entities:  

Mesh:

Year:  2002        PMID: 11845847     DOI: 10.1016/s0003-4975(01)03410-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  36 in total

1.  Long term follow-up for small pure ground-glass nodules: implications of determining an optimum follow-up period and high-resolution CT findings to predict the growth of nodules.

Authors:  Shotaro Takahashi; Nobuyuki Tanaka; Tomoaki Okimoto; Toshiki Tanaka; Kazuhiro Ueda; Tsuneo Matsumoto; Kazuto Ashizawa; Yoshie Kunihiro; Shoji Kido; Naofumi Matsunaga
Journal:  Jpn J Radiol       Date:  2011-12-22       Impact factor: 2.374

Review 2.  High-resolution computed tomography of the lungs: the borderlands of normality.

Authors:  P U Dalal; D M Hansell
Journal:  Eur Radiol       Date:  2005-12-16       Impact factor: 5.315

3.  When in doubt should we cut it out? The role of surgery in non-small cell lung cancer.

Authors:  J-E C Holty; M K Gould
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

4.  Pulmonary and thymic lymphoid hyperplasia in primary Sjögren's syndrome.

Authors:  Hideo Kobayashi; Yuichi Ozeki; Shinsuke Aida
Journal:  Jpn J Radiol       Date:  2009-03-12       Impact factor: 2.374

Review 5.  Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy.

Authors:  Hyungjin Kim; Chang Min Park; Jae Moon Koh; Sang Min Lee; Jin Mo Goo
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

Review 6.  Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Authors:  Yoshihisa Kobayashi; Tetsuya Mitsudomi
Journal:  Transl Lung Cancer Res       Date:  2013-10

7.  Computed tomography and pathology evaluation of lung ground-glass opacity.

Authors:  Hualong Yu; Shihe Liu; Chuanyu Zhang; Shaoke Li; Jianan Ren; Jingli Zhang; Wenjian Xu
Journal:  Exp Ther Med       Date:  2018-10-22       Impact factor: 2.447

Review 8.  Whack-a-mole strategy for multifocal ground glass opacities of the lung.

Authors:  Kenji Suzuki
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

9.  Synchronous pulmonary atypical adenomatous hyperplasia and metastatic osteosarcoma in a young female.

Authors:  Ken Kodama; Masahiko Higashiyama; Koji Takami; Naozumi Higaki; Kazuyuki Oda; Nobuhito Araki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-07

10.  Malignant pure pulmonary ground-glass opacity nodules: prognostic implications.

Authors:  Jong Heon Park; Kyung Soo Lee; Ji Hye Kim; Young Mog Shim; Jhingook Kim; Yong Soo Choi; Chin A Yi
Journal:  Korean J Radiol       Date:  2009 Jan-Feb       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.